RSS

 


09/19/2014

Posters

26th EORTC-NCI-AACR SYMPOSIUM

Abstract: Despite efforts to understanding and treat acute myeloid leukemia (AML), there remains a need to more comprehensive therapies to prevent AML relapses and to reach sustainable clinical responses. To explain this phenomenon, the cancer stem cells/Leukemia initiating cells (CSCs/LICs) hypothesis suggests that tumors contain a small number of tumor-initiating cells, self-renewing cancer stem cells. Unlike most cells within the… Lire la suite »

Mission

Our mission statement: Changing the cancer landscape To build a viable biopharmaceutical company that designs, develops and commercializes novel therapies intended to improve quality of life, increase duration of life and resolve serious unmet...